• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Mirum Pharmaceuticals, Inc. - common stock (NQ:MIRM)

    91.49 -0.46 (-0.50%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 442,432
    Open 92.50
    Bid (Size) 89.00 (100)
    Ask (Size) 98.85 (800)
    Prev. Close 91.95
    Today's Range 90.00 - 92.88
    52wk Range 39.51 - 109.28
    Shares Outstanding 38,297,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term ↗
    Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases. 
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire

    Performance

    YTD
    +17.2%
    +17.2%
    1 Month
    +1.5%
    +1.5%
    3 Month
    -3.0%
    -3.0%
    6 Month
    +30.7%
    +30.7%
    1 Year
    +126.1%
    +126.1%

    More News

    Read More
    News headline image
    Prediction: Buying This Biotech Stock Today Could Set You Up for Life ↗
    Via The Motley Fool
    News headline image
    Mirum (MIRM) Q2 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Mirum Pharmaceuticals (NASDAQ:MIRM) Reports Q4 2025 Revenue Beat and 2026 Outlook ↗
    Via Chartmill
    MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Embodies the Minervini Growth Momentum Strategy ↗
    Via Chartmill
    Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Offers a High-Growth Momentum and Technical Breakout Setup ↗
    Via Chartmill
    News headline image
    Mirum Pharma (MIRM) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Mirum (MIRM) Q1 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property
    News headline image
    Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position ↗
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals Completes Enrollment in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Additional Rare Cholestatic Liver Diseases
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy? ↗
    Via The Motley Fool
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Small-Cap Shudder: Russell 2000’s 1.9% Slide Signals Cracks in Economic Resilience
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum (MIRM) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    ACM Research’s AI Surge Collides With Export Controls and Chip Spending Cycles ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2025 Financial Results and Host Conference Call on February 25, 2026
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire
    News headline image
    Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mirum Pharmaceuticals, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Mirum Pharmaceuticals, Inc. - common stock publicly traded?
    Yes, Mirum Pharmaceuticals, Inc. - common stock is publicly traded.
    What exchange does Mirum Pharmaceuticals, Inc. - common stock trade on?
    Mirum Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Mirum Pharmaceuticals, Inc. - common stock?
    The ticker symbol for Mirum Pharmaceuticals, Inc. - common stock is MIRM on the Nasdaq Stock Market
    What is the current price of Mirum Pharmaceuticals, Inc. - common stock?
    The current price of Mirum Pharmaceuticals, Inc. - common stock is 91.49
    When was Mirum Pharmaceuticals, Inc. - common stock last traded?
    The last trade of Mirum Pharmaceuticals, Inc. - common stock was at 04/24/26 04:00 PM ET
    What is the market capitalization of Mirum Pharmaceuticals, Inc. - common stock?
    The market capitalization of Mirum Pharmaceuticals, Inc. - common stock is 3.50B
    How many shares of Mirum Pharmaceuticals, Inc. - common stock are outstanding?
    Mirum Pharmaceuticals, Inc. - common stock has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.